TFAP2A and breast carcinoma: Interestingly, among all the breast cancer subtypes, we observed a negative correlation between TFAP2A expression and patients’ overall survival time in basal-like breast cancer, whereas a positive correlation was observed in luminal B breast cancer (Fig. 4H, Supplementary Fig. 3C).